The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma

Author： Özdemir Nuriye   Abalı Hüseyin   Öksüzoğlu Berna   Budakoglu Burçin   Uncu Doğan   Güler Tunç   Odabaşı Hatice   Zengin Nurullah  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.27, Iss.3, 2010-09, pp. : 680-684

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort

By Pernot Simon   Mitry Emmanuel   Samalin Emmanuelle   Dahan Laetitia   Dalban Cécile   Ychou Marc   Seitz Jean-François   Turki Hajer   Mazard Thibault   Zaanan Aziz   Lepère Céline   Vaillant Jean-Nicolas   Landi Bruno   Rougier Philippe   Taieb Julien  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 341-347

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer

By Viteri Ainhoa   Muñoz Alberto   Rubio Itziar   Barceló Ramón   Martínez-Bueno Alejandro   Fernández Ricardo   Carrera Sergio   López-Vivanco Guillermo  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 397-399

Informa Healthcare

Access to resources Recommend Favorite

Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancer

By                

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1160-1164

Science Publishers

Access to resources Recommend Favorite

A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study

By Diéras Véronique   Guastalla Jean   Ferrero Jean   Curé Hervé   Weber Béatrice   Winckel Philippe   Lortholary Alain   Mayer Françoise   Paraiso Désiré   Magherini Emmanuelle   Pujade-Lauraine Eric  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 6, 2004-06 ,pp. : 489-495

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of cisplatin, 5-fluorouracil, and interferon- -2B as first line treatment of advanced urothelial cancer

By Bazarbashi S.   Pai C.   Raja M.A.   Rahal M.   Ezzat A.   Hanash K.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 3, 2003-05 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite